Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Fourth quarter revenues of $2.62 billion, up 14.5% from 2023 Fourth quarter reported diluted earnings per share ("EPS") of $1.95, up 14.7% from 2023; and adjusted diluted EPS of $2.23, up 3.7% from 20
Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
08:56am, Monday, 27'th Jan 2025
Physicians and patients to benefit from access to Quest's industry-leading test menu and broad health plan relationships in Ohio SECAUCUS, N.J. and CLEVELAND , Jan. 27, 2025 /PRNewswire/ -- Quest Dia
Should Value Investors Buy Quest Diagnostics (DGX) Stock?
10:41am, Friday, 24'th Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Quest Diagnostics Q4 Earnings Preview: What's in Store for the Stock?
08:50am, Thursday, 23'rd Jan 2025
Quest Diagnostics is likely to have driven strong performances in the key physician and hospital channels in the fourth quarter of 2024.
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
03:46am, Friday, 17'th Jan 2025
Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.
4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry
11:10am, Thursday, 16'th Jan 2025
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poise
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
08:42am, Wednesday, 08'th Jan 2025
Quality and regulatory veteran of Getinge, BD and J&J joins the Quest Diagnostics executive team SECAUCUS, N.J. , Jan. 8, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of dia
Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again
01:16pm, Friday, 03'rd Jan 2025
Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
11:00am, Thursday, 02'nd Jan 2025
SECAUCUS, N.J. , Jan. 2, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report fourth quarter and full year 2024 f
Should You Hold Quest Diagnostics Stock in Your Portfolio Now?
08:16am, Tuesday, 31'st Dec 2024
DGX's strength in the base business and the robust adoption of Advanced Diagnostics services bode well.
New Health Coaching Service on questhealth.com Set to Boost DGX Stock
08:51am, Wednesday, 04'th Dec 2024
Quest Diagnostics introduces Health Coaching on questhealth.com, helping individuals take control of their health.
Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference
09:50am, Tuesday, 03'rd Dec 2024
SECAUCUS, N.J. , Dec. 3, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will spea
Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health
08:23am, Tuesday, 03'rd Dec 2024
New service takes the guesswork out of achieving one's health goals by empowering individuals to pair Quest lab results with personalized coaching SECAUCUS, N.J,, Dec. 3, 2024 /PRNewswire/ -- Personal
Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 21'st Nov 2024
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management
01:05pm, Friday, 15'th Nov 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusi
